In view of the consistent expression of PI3K p110α in primary GBM samples and its association with EGFR and mTOR pathway activation, we next evaluated a panel of pharmacological isoform-specific inhibitors in GBM cell lines and ex vivo cultures expressing the EGFR/PI3K p110α/p-S6 module. This evidence concerns the gene EGFR and glioblastoma.